Skip to main content

Advertisement

Log in

High Sensitivity C Reactive Protein: An Adjunct Diagnosis in Ruling Out Pediatric Tuberculosis

  • Original Research Article
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

The utility of C-reactive protein (CRP) as a marker of disease severity, therapeutic response and prognosis in tuberculosis has been suggested. This study aims to determine the levels of high sensitivity CRP (hs CRP) among the pediatric tuberculosis cases. A case control study was conducted on 60 clinically diagnosed (clinical findings and radiography and/or contact history and/or Mantoux test) or microbiologically confirmed (smear and/or culture and/or Cartridge based Nucleic Acid Amplification test positive) pediatric tuberculosis cases ≤ 12 years. hs CRP levels were estimated in the cases and healthy controls using ELISA. Median levels of serum hs CRP were significantly higher in pediatric tuberculosis cases (25 mg/l) as compared to controls (0.530 mg/l). No significant correlation was found with age, gender, site of tuberculosis or presence of dissemination. Lower levels were found with palpable lymphadenopathy. Levels were not significantly different between microbiologically confirmed cases and those who were negative by one or more of the microbiological tests of staining, culture and cartridge based nucleic acid amplification test. hs CRP can be used in diagnostic algorithms of pediatric tuberculosis to rule out tuberculosis. Further studies could help in determining the prognostic and therapeutic response of hs CRP among children leading to better management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. World Health Organization. Global tuberculosis report 2017. Geneva: World Health Organisation; 2017. Available from: http://www.who.int/tb/publications/global_report/MainText_13Nov2017.pdf?ua=1. Accessed 6 Mar 2018.

  2. Raizada N, Sachdeva KS, Swaminathan S, Kulsange S, Khaparde SD, Nair SA, et al. Piloting Upfront Xpert MTB/RIF testing on various specimens under programmatic conditions for diagnosis of TB & DR TB in paediatric population. PLoS ONE. 2015;10(10):e0140375.

    Article  Google Scholar 

  3. Dodd PJ, Yuen CM, Sismanidis C, Seddon JA, Jenkins HE. The global burden of Tuberculosis mortality in children: a mathematical modeling study. Lancet Glob Health. 2017;5(9):e898–906.

    Article  Google Scholar 

  4. Sandgren A, Cuevas LE, Dara M, Gie RP, Grzemska M, Hawkridge A, et al. Childhood tuberculosis: progress requires an advocacy strategy now. Eur Respir J. 2012;40(2):294–7.

    Article  Google Scholar 

  5. Kalra A. Care seeking and treatment related delay among childhood tuberculosis patients in Delhi, India. Int J Tuberc Lung Dis. 2017;21(6):645–50.

    Article  CAS  Google Scholar 

  6. Singh S, Singh A, Prajapati S, Kabra SK, Lodha R, Mukherjee A, et al. Xpert MTB/RIF assay can be used on archived gastric aspirate and induced sputum samples for sensitive diagnosis of paediatric tuberculosis. BMC Microbiol. 2015;15:191.

    Article  Google Scholar 

  7. Zumla A, Wallis R, Doherty M, Klein N, Parida S, Olesen O, et al. Joint TDR/EC expert consultation on biomarkers in tuberculosis. Geneva: World Health Organization; 2008.

    Google Scholar 

  8. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Investig. 2003;111(12):1805–12.

    Article  CAS  Google Scholar 

  9. Young B, Gleeson M, Cripps AW. C-reactive protein: a critical review. Pathology. 1991;23(2):118–24.

    Article  CAS  Google Scholar 

  10. Drain PK, Mayeza L, Bartman P, Hurtadol R, Moodley P, Varghese S, et al. Diagnostic accuracy and clinical role of rapid C-reactive protein testing in HIV-infected TB suspects in South Africa. Int J Tuberc Lung Dis. 2014;18(1):20–6.

    Article  CAS  Google Scholar 

  11. Rao S, Bernhardt V. Serum C-reactive protein in pulmonary tuberculosis: correlation with bacteriological load and extent of disease. Infect Dis Clin Pract. 2009;17(5):314–6.

    Article  Google Scholar 

  12. Kumar M, Swati, Verma M. Prognostic value of C-reactive protein in pediatric tubercular patients on ATT. IOSR J Dent Med Sci. 2016;15(6):52–7.

    Google Scholar 

  13. Yoon C, Davis JL, Huang L, Muzoora C, Byakwaga H, Scibetta C, et al. Point of care C-reactive protein testing to facilitate implementation of Isoniazid preventive therapy for people living with HIV. J Acquir Immune Defic Syndr. 2014;65(5):551–6.

    Article  CAS  Google Scholar 

  14. Central TB Division, Government of India. Revised national tuberculosis control programme: technical and operational guidelines for TB control in India. New Delhi: Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare; 2016. p. 1–269.

  15. Singh V, Mahto D. Antitubercular drugs and RNTCP guidelines for childhood tuberculosis. In: Gupta P, Menon PSN, Ramji S, Lodha R, editors. PG Textbook of pediatrics: infections and systemic disorders. 2nd ed. New Delhi: Jaypee Brothers Medical Publishers; 2018. p. 1348.

    Google Scholar 

  16. Forbes BA, Sahm DF, Weissfeld AS. Mycobacteria and other bacteria with unusual growth requirements. In: Forbes BA, Sahn DF, Weissfeld AS, editors. Bailey & Scott’s diagnostic microbiology. 13th ed. Missouri: Mosby Elsevier Inc; 2014. p. 484–512.

    Google Scholar 

  17. Central TB Division, Government of India. Revised National TB Control Programme Training Manual for Mycobacterium tuberculosis culture and drug susceptibility testing. New Delhi: Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare; 2009. Available from: http://www.tbcindia.nic.in/showfile.php?lid=2991. Accessed 3 Oct 2017.

  18. Gupta R, Garg A, Venkateshwar V, Kanitkar M. Spectrum of childhood tuberculosis in BCG vaccinated and unvaccinated children. Med J Armed Forces India. 2009;65(4):305–7.

    Article  CAS  Google Scholar 

  19. Devrim I, Aktürk H, Bayram N, Apa H, Tulumoğlu S, Devrim F, et al. Differences between pediatric extra-pulmonary and pulmonary tuberculosis: a warning sign for the future. Mediterr J Hematol Infect Dis. 2014;6(1):e2014058.

    Article  Google Scholar 

  20. Jain SK, Ordonez A, Kinikar A, Gupte N, Thakar M, Mave V, et al. Pediatric tuberculosis in young children in India: a prospective study. Biomed Res Int. 2013;2013:783698.

    PubMed  PubMed Central  Google Scholar 

  21. Satyanarayana S, Shivashankar R, Vashist RP, Chauhan LS, Chadha SS, Dewan PK, et al. Characteristics and programme-defined treatment outcomes among childhood tuberculosis (TB) patients under the national TB programme in Delhi. PLoS ONE. 2010;5(10):e13338.

    Article  Google Scholar 

  22. Kumar NP, Anuradha R, Andrade BB, Suresh N, Ganesh R, Shankar J, et al. Circulating biomarkers of pulmonary and extrapulmonary tuberculosis in children. Clin Vaccine Immunol. 2013;20(5):704–11.

    Article  CAS  Google Scholar 

  23. Wilson D, Badri M, Maartens G. Performance of serum C-reactive protein as a screening test for smear-negative tuberculosis in an ambulatory high HIV prevalence population. PLoS ONE. 2011;6(1):e15248.

    Article  CAS  Google Scholar 

  24. Rebecca B, Chacko A, Verghese V, Rose W. Spectrum of pediatric tuberculosis in a tertiary care setting in South India. J Trop Pediatr. 2018. https://doi.org/10.1093/tropej/fmy007.

    Article  PubMed  Google Scholar 

  25. Brown J, Clark K, Smith C, Hopwood J, Lynard O, Toolan M, et al. Variation in C-reactive protein response according to host and mycobacterial characteristics in active tuberculosis. BMC Infect Dis. 2016;16:265.

    Article  Google Scholar 

  26. Gupta N, Kashyap B, Dewan P, Hyanki P, Singh NP. Clinical spectrum of pediatric tuberculosis: a microbiological correlation from a tertiary care center. J Trop Pediatr. 2018. https://doi.org/10.1093/tropej/fmy026.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bineeta Kashyap.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kashyap, B., Gupta, N., Dewan, P. et al. High Sensitivity C Reactive Protein: An Adjunct Diagnosis in Ruling Out Pediatric Tuberculosis. Ind J Clin Biochem 35, 211–217 (2020). https://doi.org/10.1007/s12291-018-0806-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-018-0806-2

Keywords

Navigation